Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunofluorescent patterns and specificity of human antinuclear antibodies.

× No keyword cloud information.

30 in total

1. GAMMA-2, GAMMA-1A AND GAMMA-1M ANTINUCLEAR FACTORS IN HUMAN SERA.

Authors: E V BARNETT; J J CONDEMI; J P LEDDY; J H VAUGHAN
Journal: J Clin Invest Date: 1964-06 Impact factor: 14.808

2. RHEUMATOID ARTHRITIS WITH SEROLOGIC EVIDENCE SUGGESTING SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL, SEROLOGIC AND CHROMATOGRAPHIC STUDIES.

Authors: R F WILLKENS; J L DECKER
Journal: Arthritis Rheum Date: 1963-12

3. COMPARATIVE STUDY FOR THE DETECTION OF ANTINUCLEAR FACTORS WITH THE FLUORESCENT ANTIBODY TECHNIQUE.

Authors: W HIJMANS; H R SCHUIT; E MANDEMA; R L NIENHUIS; T E FELTKAMP; E J HOLBOROW; G D JOHNSON
Journal: Ann Rheum Dis Date: 1964-01 Impact factor: 19.103

4. HETEROGENEITY OF ANTINUCLEAR FACTORS IN LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS.

Authors: E V BARNETT; R F BAKEMEIER; J P LEDDY; J H VAUGHAN
Journal: Proc Soc Exp Biol Med Date: 1965-03

5. 1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors: M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal: Bull Rheum Dis Date: 1958-12

6. Isothiocyanate compounds as fluorescent labeling agents for immune serum.

Authors: J L RIGGS; R J SEIWALD; J H BURCKHALTER; C M DOWNS; T G METCALF
Journal: Am J Pathol Date: 1958 Nov-Dec Impact factor: 4.307

7. The immunofluorescent tumor imprint technique. II. The frequency of antinuclear factors in connective tissue diseases and dermatoses.

Authors: T K Burnham; G Fine; T R Neblett
Journal: Ann Intern Med Date: 1966-07 Impact factor: 25.391

8. Leucocyte-specific anti-nuclear factors in patients with felty's syndrome, rheumatoid arthritis, systemic lupus erythematosus and other diseases.

Authors: V Faber; P Elling
Journal: Acta Med Scand Date: 1966-03

Review 9. Antinuclear antibodies and nuclear antigens.

Authors: E V Barnett
Journal: Calif Med Date: 1966-06

10. Nuclear fluorescence employing antinucleoside immunoglobulins.

Authors: W J Klein; S M Beiser; B F Erlanger
Journal: J Exp Med Date: 1967-01-01 Impact factor: 14.307

10 in total

1. Evaluation of an automated chemiluminescent immunoassay kit for antinuclear antibodies in autoimmune diseases.

Authors: Yaron Zafrir; Boris Gilburd; Marina Garcia Carrasco; Shaye Kivity; María Sánchez-Castañón; Marcos López-Hoyos; Mathilda Mandel; Magdalena Szmyrka; Yehuda Shoenfeld; Nancy Agmon-Levin
Journal: Immunol Res Date: 2013-07 Impact factor: 2.829

2. Immunological detection of nucleic acids and antibodies to nucleic acids and nuclear antigens by counterimmunoelectrophoresis.

Authors: P H Schur; D DeAngelis; J M Jackson
Journal: Clin Exp Immunol Date: 1974-05 Impact factor: 4.330

3. Detection of antinuclear antibodies in NZB and other mouse strains.

Authors: B V Siegel; M Brown; J I Morton
Journal: Immunology Date: 1972-03 Impact factor: 7.397

4. Circulating antibodies in human connective tissue malignancy.

Authors: M Moore; L A Hughes
Journal: Br J Cancer Suppl Date: 1973-08

5. Character of anti-DNA antibodies in systemic lupus erythematosus.

Authors: S A Cohen; G R Hughes; G L Noel; C L Christian
Journal: Clin Exp Immunol Date: 1971-04 Impact factor: 4.330

6. Relation of titred peripheral pattern ANA to anti-DNA and disease activity in systemic lupus erythematosus.

Authors: R J Weitzman; S E Walker
Journal: Ann Rheum Dis Date: 1977-02 Impact factor: 19.103

7. Method for avoiding false-positive results occurring in immunoglobulin M enzyme-linked immunosorbent assays due to presence of both rheumatoid factor and antinuclear antibodies.

Authors: Y Naot; E V Barnett; J S Remington
Journal: J Clin Microbiol Date: 1981-07 Impact factor: 5.948

8. False-positive anti-Toxoplasma fluorescent-antibody tests in patients with antinuclear antibodies.

Authors: F G Araujo; E V Barnett; L O Gentry; J S Remington
Journal: Appl Microbiol Date: 1971-09

9. Failure to demonstrate any interaction between polyclonal rheumatoid factors and IgG antinuclear antibodies or other IgG autoantibodies.

Authors: L Scott-Morgan; R S Lloyd
Journal: Clin Exp Immunol Date: 1980-08 Impact factor: 4.330

10. Poly(ADP-ribose) synthesis, a marker of granulocyte differentiation.

Authors: K Ikai; K Ueda; M Fukushima; T Nakamura; O Hayaishi
Journal: Proc Natl Acad Sci U S A Date: 1980-06 Impact factor: 11.205

10 in total